{
  "id": 20446603,
  "title": "#CTAD26: Priavoid’s amyloid-detangling pill PRI-002 fails Phase 2 study in Alzheimer’s",
  "url": "https://urgent.news/2026/11/17/ctad26-priavoids-amyloid-detangling-pill-pri-002-fails-phase-2-study",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-17T15:05:43.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/priavoids-amyloid-detangling-pill-pri-002-fails-phase-2-study-in-alzheimers/"
  },
  "original_language": "en",
  "account": null,
  "summary": "BOSTON — For nearly a decade, the German biotech startup Priavoid has been working on a pill to break up small clumps of amyloid proteins that accumulate in the brains of people with Alzheimer’s disease. Now ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}